1. Home
  2. CYCC vs NITO Comparison

CYCC vs NITO Comparison

Compare CYCC & NITO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • NITO
  • Stock Information
  • Founded
  • CYCC 1992
  • NITO 2009
  • Country
  • CYCC United States
  • NITO Israel
  • Employees
  • CYCC N/A
  • NITO N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • NITO
  • Sector
  • CYCC Health Care
  • NITO
  • Exchange
  • CYCC Nasdaq
  • NITO NYSE
  • Market Cap
  • CYCC 2.3M
  • NITO 2.2M
  • IPO Year
  • CYCC N/A
  • NITO N/A
  • Fundamental
  • Price
  • CYCC $0.34
  • NITO $0.18
  • Analyst Decision
  • CYCC Buy
  • NITO
  • Analyst Count
  • CYCC 2
  • NITO 0
  • Target Price
  • CYCC $11.00
  • NITO N/A
  • AVG Volume (30 Days)
  • CYCC 431.0K
  • NITO 541.1K
  • Earning Date
  • CYCC 11-12-2024
  • NITO 11-14-2024
  • Dividend Yield
  • CYCC N/A
  • NITO N/A
  • EPS Growth
  • CYCC N/A
  • NITO N/A
  • EPS
  • CYCC N/A
  • NITO N/A
  • Revenue
  • CYCC $74,000.00
  • NITO $175,308.00
  • Revenue This Year
  • CYCC N/A
  • NITO N/A
  • Revenue Next Year
  • CYCC $88.68
  • NITO N/A
  • P/E Ratio
  • CYCC N/A
  • NITO N/A
  • Revenue Growth
  • CYCC N/A
  • NITO N/A
  • 52 Week Low
  • CYCC $0.32
  • NITO $0.16
  • 52 Week High
  • CYCC $4.00
  • NITO $2.40
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 37.88
  • NITO 39.52
  • Support Level
  • CYCC $0.33
  • NITO $0.17
  • Resistance Level
  • CYCC $0.42
  • NITO $0.20
  • Average True Range (ATR)
  • CYCC 0.04
  • NITO 0.02
  • MACD
  • CYCC 0.01
  • NITO -0.00
  • Stochastic Oscillator
  • CYCC 8.21
  • NITO 18.29

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About NITO N2OFF INC

N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork.

Share on Social Networks: